Healthcare / Medical - PharmaceuticalsUpdated 2026-05-10 22:07 UTC

LON/0J8Z stock hub

LON/0J8Z has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0J8Zis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

15.8B

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0J8Z

In the news

Latest news · LON/0J8Z

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E25.9

P25 12.9P50 16.9P75 23.5

Trailing P/E24.5

P25 15.9P50 22.9P75 35.8

ROE33.8

P25 -54.2P50 2.1P75 13.7

ROIC18.5

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0J8Z market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

214

Groups with data

Currency

USD

Showing 214 of 214 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	UK
Employees	8,650
Employees Change	-380%
Employees Change Percent	-4.21
Enterprise value	$16.8B
Exchange	London Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Medical - Pharmaceuticals
Isin	US4523271090
Last refreshed	2026-05-10
Market cap	$15.8B
Price	$137
Price currency	USD
Rev Per Employee	383,258.05x
Sector	Healthcare
Sic	3826
Symbol	lon/0J8Z
Website	https://www.illumina.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.07%
EV Earnings	26.13x
EV/EBIT	25.83x
EV/EBITDA	18.47x
EV/FCF	22.89x
EV/Sales	5.2x
FCF yield	4.65%
Forward P/E	25.92x
P/B ratio	7.82x
P/E ratio	24.54x
P/S ratio	4.77x
PE Ratio10 Y	54.01x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	20.15%
EBITDA Margin	26.29%
FCF margin	22.17%
Gross margin	68.29%
Gross Profit	$2.3B
Gross Profit Growth	0.81%
Gross Profit Growth Q	5.13%
Gross Profit Growth3 Y	0.08%
Gross Profit Growth5 Y	4.78%
Net Income	$641.9M
Net Income Growth Q	2.29%
Net Income Growth Quarters	2%
Net Income Growth Years	1%
Net Income Growth5 Y	6.25%
Pretax Margin	24.15%
Profit Margin	19.42%
Profit Per Employee	$74,418
Profitable Years	1
ROA	8.68
Roa5y	2.88
ROCE	17.72
ROE	33.82
Roe5y	-11.3
ROIC	18.46
Roic5y	6.39

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	81.74%
Cagr3y	-10.79%
Cagr5y	-18.31%
EPS Growth Q	6.1
EPS Growth Quarters	2
EPS Growth Years	1
EPS Growth5 Y	5.21
FCF Growth	11.19%
FCF Growth Q	20.67%
FCF Growth5 Y	1.82%
OCF Growth	12.8%
OCF Growth Q	20.42%
OCF Growth10 Y	5.01%
OCF Growth3 Y	69.9%
OCF Growth5 Y	0.85%
Revenue Growth	1.29x
Revenue Growth Q	4.8x
Revenue Growth Quarters	3x
Revenue Growth Years	0x
Revenue Growth3 Y	-0.41x
Revenue Growth5 Y	4.81x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.69
Assets	$4.9B
Cash	$869.1M
Current Assets	$2B
Current Liabilities	$1.1B
Debt	$1.9B
Debt EBITDA	$2.06
Debt Equity	$0.95
Debt FCF	$2.61
Equity	$2B
Interest Coverage	8.85
Liabilities	$2.9B
Long Term Assets	$2.9B
Long Term Liabilities	$1.8B
Net Cash	$-1B
Net Cash By Market Cap	$-6.63
Net Debt EBITDA	$1.2
Net Debt Equity	$0.52
Net Debt FCF	$1.43
Tangible Book Value	$723.9M
Tangible Book Value Per Share	$4.76
WACC	11.12

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.75
Inventory Turnover	2.43
Net Working Capital	$448.5M
Quick ratio	1.23
Working Capital	$881.9M
Working Capital Turnover	$2.75

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	2.67%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	81.67%
200-day SMA	118.7
3Y total return	-29.02%
50-day SMA	127.6
50-day SMA vs 200-day SMA	50over200
5Y total return	-63.63%
All Time High	545.8
All Time High Change	-74.9%
All Time High Date	2021-02-12
All Time Low	68.69
All Time Low Change	99.49%
All Time Low Date	2025-04-09
ATR	6.16
Beta	1.42
Ch YTD	4.29
High	140.5
High52	155.1
High52 Date	2026-01-22
High52ch	-11.66%
Low	135.1
Low52	75.45
Low52 Date	2025-05-09
Low52ch	85.38%
Ma50ch	7.4%
Price vs 200-day SMA	15.49%
RSI	60.27
RSI Monthly	52.96
RSI Weekly	59.36
Sharpe ratio	1.36x
Sortino ratio	2.44
Total Return	2.67%
Tr YTD	4.29
Tr1m	7.75%
Tr1w	1.95%
Tr3m	14.93%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$665.9M
Operating Income Growth	37.64
Operating Income Growth Q	8.7
Operating Income Growth5 Y	8.67
Operating margin	20.15

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	147,052,875%
Net Borrowing	-3,667,570
Shares Insiders	2.73%
Shares Institutions	107.72%
Shares Qo Q	0%
Shares Yo Y	-2.67%
Short Ratio	4.18

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$535.8M
Average Volume	585.9x
Bv Per Share	13.25
CAPEX	$-115.9M
Ch1m	7.75
Ch1w	1.95
Ch1y	81.67
Ch3m	14.93
Ch3y	-31.02
Ch5y	-64.65
Ch6m	13.21
Change	-0.52%
Change From Open	-2.16
Close	137.8
Days Gap	1.68
Depreciation Amortization	198,048,780
Dollar Volume	47,549.4
Earnings Date	2026-04-30
EBIT	$665.9M
EBITDA	$869.1M
EPS	$4.15
F Score	6
FCF	$732.9M
FCF EV Yield	4.37x
Financing CF	-601,976,000
Fiscal Year End	December
Founded	1,998
Goodwill	941,831,976
Graham Number	46.90601
Graham Upside	-65.77
Income Tax	$156.5M
Investing CF	-269,384,260
Is Primary Listing	0
Last Earnings Date	2026-04-30
Last Report Date	2026-03-29
Lynch Fair Value	$34.88
Lynch Upside	-74.54
Ma150	125.1
Ma150ch	9.55%
Ma20	131.4
Ma20ch	4.27%
Net CF	-18,059,280
Next Earnings Date	2026-07-30
Open	140.1
P FCF Ratio	21.49
P OCF Ratio	18.56
Position In Range	36.21
Ppne	825,936,764
Price Date	2026-05-08
Price EBITDA	$18.13
Ptbv Ratio	21.76
Relative Volume	0.6x
Revenue	3,305,600,710x
SBC By Revenue	5.96x
Share Based Comp	197,147,140
Tax By Revenue	4.73x
Tax Rate	19.6%
Tr6m	13.21%
Volume	347
Z Score	3.83

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does LON/0J8Z pay a dividend?

Capital-return profile for this ticker.

Performance

LON/0J8Z stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0J8Z?

Insider, institutional, and short-interest positioning.

Institutional ownership

+107.7%

Share of float held by funds and institutions

Insider ownership

+2.7%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

LON/0J8Z momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

60.3

Neutral momentum band

Price vs 200-day MA

+15.5%

50/200-day relationship not available

Beta (5Y)

1.42

More volatile than the market

Sharpe ratio

1.36

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0J8Z

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0J8Z stock rating?

lon/0J8Z is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0J8Z analysis?

The full report lives at /stocks/lon/0J8Z/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0J8Z?

The latest report frames lon/0J8Z around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0J8Z page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.